Will Canopy Growth stock go up?

According to Danelfin AI, Canopy Growth has today an AI Score of 7/10 (Buy rating), because its probability of beating the market in 3 months (59.43%) is +8.61% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Canopy Growth stock?

The Canopy Growth target price is $1.57 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Canopy Growth stock right now?

Canopy Growth has today a Buy rating (AI Score 7/10), according to Danelfin AI. Its probability of beating the market in 3 months (59.43%) is +8.61% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Canopy Growth stock is a good buy .

Is Canopy Growth undervalued right now?

Based on analysts, the average price target upside for Canopy Growth is +65.26% (1Y). According to Danelfin AI, Canopy Growth has today an AI Score of 7/10 (Buy Rating).

What was the price range of Canopy Growth stock over the past 12 months?

The Canopy Growth stock price range over the past 12 months has been $0.86 - $1.92.

What is going on with Canopy Growth stock in the last 3 months?

The Canopy Growth stock performance in the last quarter has been +0.05%.

Does Canopy Growth offer dividend payments?

No, Canopy Growth does not currently pay dividends.

What is the current market capitalization of Canopy Growth?

Canopy Growth's market cap is $396.91M, as of 2026-07-02 08:00.

When is the next CGC earnings report date?

CGC will publish its next earnings report on 2026-06-15.

Canopy Growth Corp (CGC) AI Stock Analysis

Advanced Chart

Custom range

Jul 2, 2025

→

Jul 2, 2026

Custom range

Jul 2, 2025

→

Jul 2, 2026

CGC AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Momentum+3.77%
Direction and strength of recent price movements
Valuation+2.43%
How the stock is priced relative to its fundamentals
Volatility+1.44%
How much the stock price tends to fluctuate
Earnings Quality+0.94%
Stability and reliability of reported earnings
Size & Liquidity+0.30%
Company size and trading liquidity

Profitability-0.23%
Profitability and operating efficiency metrics
Sentiment-0.04%
How analysts and the market view the stock

CGC probability advantage of beating the market (3M):

+8.61%

AI Score

Buy

Canopy Growth (CGC) has an AI Score of 7/10 (Buy) because, according to an overall analysis, it has a probability advantage of +8.61% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of CGC (59.43%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
CGC probability advantage of beating the market (3M)+8.61%
CGC probability of beating the market (3M)59.43%

CGC probability advantage of beating the market (3M): +8.61%

The AI-powered overall analysis of Canopy Growth (CGC) is based on the 25 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of CGC:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Technical	Technicals Impact (Long Tail)	-	N/A	+2.40%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+1.90%
Fundamental	Operating Cash Flow (Qtr Discrete)	-13.08		+0.94%
Sentiment	Institutional Ownership	7.75%		-0.73%
Technical	ATR (14d Volatility)	0.05	N/A	+0.69%
Sentiment	Sentiment Impact (Long Tail)	-	N/A	+0.68%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-0.58%
Technical	ATR (90d Volatility)	0.09	N/A	+0.57%
Technical	Performance (YTD)	-0.17%		+0.54%
Sentiment	Earnings Countdown	-11		+0.53%
Technical	Upgrade to unlock			-0.43%
Technical	Upgrade to unlock			+0.43%
Technical	Upgrade to unlock			-0.36%
Sentiment	Upgrade to unlock			+0.35%
Fundamental	Upgrade to unlock			+0.31%

Rest of Alpha Signals: +0.99%

CGC probability advantage of beating the market (3M)Total:+8.61%
CGC AI Score

Significant changes Vs previous day

CGC Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$0.95
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 7/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 7/10

CGC Proven Buy Signal & Price Forecast

This is the price chart for CGC from January 1, 2026 until today. The chart indicates, in green, the 53 days when the stock received a Buy/Strong Buy rating (buy signals, AI Score 7 to 10).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Buy signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Buy signals

Forecast:

1 Month
3 Months
6 Months
1 Year

CGC Average Past Performance & Win Rate

Three months after its 157 Buy signals since July 2026, CGC had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

157 Past CGC Buy Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-42.02%
Average Alpha				-58.21%
Win Rate (% Positive Perf.)				0.00%
% Positive Alpha				0.00%

CGC Frequently Asked Questions

Will Canopy Growth stock go up?
According to Danelfin AI, Canopy Growth has today an AI Score of 7/10 (Buy rating), because its probability of beating the market in 3 months (59.43%) is +8.61% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Canopy Growth stock?
Is it a good time to buy, sell, or hold Canopy Growth stock right now?
Is Canopy Growth undervalued right now?
What was the price range of Canopy Growth stock over the past 12 months?
What is going on with Canopy Growth stock in the last 3 months?
Does Canopy Growth offer dividend payments?
What is the current market capitalization of Canopy Growth?
When is the next CGC earnings report date?

Canopy Growth Corp Company Profile

Canopy Growth Corporation, in conjunction with its subsidiary businesses, is a pioneering name in the production, dissemination, and retail of cannabis and hemp-infused commodities primarily targeted for both recreational and therapeutic use across Canada, the US, and Germany. It extends its operations through two fundamental divisions - Global Cannabis and Other Consumer Products.

The company’s product repertoire encompasses dried flower derived from cannabis, extracts, highly condensed formulas like beverages and gummies along with vaporisers. The market visibility and patronage of their products are escalated through a broad spectrum of renowned brands such as Tweed, 7ACRES Craft Collective, DOJA, Ace Valley down to Whisl, Truverra among others.

Undergoing significant rebranding strategy previously known as Tweed Marijuana Inc., the corporation embraced the identity of Canopy Growth Corporation in September 2015 to better align with its evolved vision and industry position. Since its inception in 2009, Canopy Growth Corporation has been flourishing under robust leadership strategy while strategically positioned in Smiths Falls, Canada.

Sector:
Country:Canada
Industry:
Address:1 Hershey Dr, Smiths Falls
Employees:960
Website:canopygrowth.com

Pros

First-mover advantage in Canadian recreational cannabis market

Established distribution channels across Canadian provinces

Broad product portfolio spanning various cannabis formats

Leverageable infrastructure for future international market entry

Brand equity built through early market presence

Cons

Intense regulatory compliance costs in cannabis operations

High capital expenditure requirements for cultivation facilities

Persistent competition from illicit cannabis markets

Market oversupply leading to price compression

Restricted access to conventional capital due to federal illegality

Pros

Cons

Company

AI Score

Compare

ACBAurora Cannabis Inc

IMCCIM Cannabis Corp

TLRYTilray Brands Inc

OGIOrganigram Global Inc

CRONCronos Group Inc

Company

AI Score

Compare

CGC Top 10 Industry Stocks

Pharmaceuticals

	Company	AI Score	Compare
1	LBRXLB Pharmaceuticals Inc
2	PAHCPhibro Animal Health Corp
3	EYPTEyePoint Inc
4	JAZZJazz Pharmaceuticals PLC
5	GSKGSK plc
6	RAPPRapport Therapeutics Inc
7	PHVSPharvaris NV
8	LENZLENZ Therapeutics Inc
9	MAZEMaze Therapeutics Inc
10	TARSTarsus Pharmaceuticals Inc

	Company	AI Score	Compare

	Company	AI Score	Compare
1	COGTCogent Biosciences Inc

Company

AI Score

Compare

COGTCogent Biosciences Inc

Company

AI Score

Compare

CGC Stock AI Analysis